" " indicates required fields
Threat analysis and risk assessment in hours, not months.
And it updates itself.
Manual threat modeling and risk assessment is the bottleneck that delays every product launch. EVSec automates threat analysis from architecture input to regulatory work product and risk scores, then keeps it current and live as your product evolves.
Automated
UN R155,
ISO 21434,
FDA 524B
0
Workshop sessions, spreadsheet assembly, expert review cycles. By the time it is done, the architecture has changed.
A new interface, a software update, a supplier component change. Each one requires a full re-run of the threat modeling process.
Quality threat modeling depends on specialists who are always oversubscribed. One person bottlenecks the entire program.
A static threat analysis report cannot respond when a new CVE lands or a regulation changes. It is a snapshot of risk, not a view of current risk.
Manual threat modeling produces a snapshot
EVSec produces a living threat model
UN R155
ISO/SAE 21434
FDA 524B
AIS 189
Auto-ISAC ATM
ENISA
ISO 14971
IEC 62443
EU CRA
ANSI/AAMI SW96:2023
MITRE ATT&CK
"We needed 75% faster threat analysis to meet production timelines without compromising quality. EVSec delivered that."
Tier 1 Automotive Supplier
CRO
C2A Security
VP and GM, Medical Technology
C2A Security
Ken Zalevsky brings over 20 years of medical device cybersecurity experience to his role at C2A Security, where he serves as VP and GM, Medical Technology, following the acquisition of Vigilant Ops in October 2025. A former Bayer executive, Ken founded Vigilant Ops in 2019 after witnessing the consequences of inadequate technical preparation in the healthcare industry. He is an active contributor to CISA’s SBOM working groups and a frequent speaker on software supply chain security. Ken’s mission: transform SBOM from a compliance checkbox into operational intelligence that keeps patients safe while streamlining regulatory processes.